Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
about
Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancersThe impact of sphingosine kinase-1 in head and neck cancer.Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.Immunology and Immunotherapy of Head and Neck CancerCurrent and potential inflammation targeted therapies in head and neck cancer.mPGES-1 as a target for cancer suppression: A comprehensive invited review "Phospholipase A2 and lipid mediators".Immunotherapy for head and neck cancer patients: shifting the balance.The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.Head and Neck Carcinoma Immunotherapy: Facts and Hopes.Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies.Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma.Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2.MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.
P2860
Q28743513-0ED5DF6E-B5F5-48FA-B9EA-50736E3B6A9AQ33649748-918AA6A9-A875-4D0E-98F7-6B075EB3AC31Q33848015-2D7A2B0F-5ECE-4B36-91A3-9C75EC49DC35Q33895607-D01BA5D2-0D20-4476-A46F-9F6D4FC7542EQ34348741-D768227F-06E7-405A-B7C9-16CEDFFE86C3Q36100837-50B92F21-0341-4B02-87B4-2EEAC2EBF883Q37316179-B67F55A9-AD1B-4FCC-B591-D1BF39D87C60Q37693270-05241BA7-4F9F-482B-A122-75783CE942E4Q38068966-32DBBEFF-AFDF-43EB-8565-BDFA4AAD1A06Q38079588-904E8825-22FE-45A9-95A2-54B392B1DAA0Q38650710-F2B8734D-9FA3-4C38-91AC-746EAE4384ACQ38851114-D43056A2-B9B2-4CA2-9283-55B2E56DD691Q38953336-BFB23492-6FF4-40B1-A17F-24BC985F994EQ39641982-416047C0-D1B4-4AF9-B170-82C4167983FAQ39650631-7DE69555-6CE9-434E-B73E-B68A86DAC001Q41875453-4BB7F887-9C8C-49C1-9EE2-0031B6B2D18EQ47133718-56E50C57-3113-407A-97E7-58C120922052
P2860
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
@en
type
label
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
@en
prefLabel
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
@en
P50
P356
P1433
P1476
Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.
@en
P2093
María-Teresa Fernández-Figueras
P304
P356
10.1002/HED.20850
P577
2008-09-01T00:00:00Z